Sunshine Biopharma

Sunshine Biopharma EPS

The Earnings per Share (EPS) of Sunshine Biopharma (SBFM) as of Nov 16, 2026 is -12.18 USD. In the previous year, Earnings per Share (EPS) was -1.99 USD — a change of 512.08% (lower).

EPS

-12.18USD

YoY

512.08%

Last updated:

Earnings per Share (EPS) of Sunshine Biopharma is 2025 -12.18 USD. Earnings per Share (EPS) of Sunshine Biopharma was 2024 -1.99 USD. It decreases by 512.08% lower compared to the previous year.

The Sunshine Biopharma EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
-16.07 USD
Jan 1, 2021
-34.69 USD
Jan 1, 2022
-11.84 USD
Jan 1, 2023
-3,755.04 USD
Jan 1, 2024
-1.99 USD
Jan 1, 2025
-12.18 USD
Jan 1, 2026 (e)
-1.95 USD
Jan 1, 2027 (e)
-0.40 USD
The Sunshine Biopharma EPS history
YEAREPSYoY
est-0.40USD-79.49%
est-1.95USD-83.99%
-12.18USD+512.08%
-1.99USD-99.95%
-3,755.04USD+31,611.73%
-11.84USD-65.87%
-34.69USD+115.81%
-16.07USD+34,095.74%
-0.05USD-84.16%
-0.30USD-46.53%
-0.55USD+83.57%
-0.30USD-100.00%
-8,264.54USD-57.27%
-19,342.10USD-22.37%
-24,914.83USD+251.93%
-7,079.52USD+27.28%
-5,562.02USD+4,138.70%
-131.22USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunshine Biopharma Stock analysis

What does Sunshine Biopharma do? Sunshine Biopharma Inc., based in Pointe-Claire, Quebec, is a biotechnology company focused on developing and commercializing oncology and antiviral drugs. The company employs 46 full-time staff and operates through two segments: generic prescription pharmaceuticals and over-the-counter products. It develops proprietary drugs such as Adva-27a for pancreatic cancer, K1.1 mRNA for liver cancer, and SBFM-PL4 for antiviral applications. The firm also manages subsidiaries NoraPharma Inc. and Sunshine Biopharma Canada Inc., which handle generic and OTC product portfolios respectively. Sunshine Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunshine Biopharma stock

Earnings per Share (EPS) of Sunshine Biopharma is -12.18 USD in 2025.

Earnings per Share (EPS) of Sunshine Biopharma changed from -1.99 USD to -12.18 USD, representing a 512.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Sunshine Biopharma since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Sunshine Biopharma

All Key Metrics — Sunshine Biopharma